Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents
Pharmaceuticals · 24.03.2024 · 17 (4) · 410
DOI: 10.3390/ph17040410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 24.03.2024. Verfasst von Sundas Tariq und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Hazara University, Mansehra 21120, Pakistan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.
Themen: Demenz
Abstract (Originalsprache)
Benzimidazole-based pyrrole/piperidine analogs (1–26) were synthesized and then screened for their acetylcholinesterase and butyrylcholinesterase activities. All the analogs showed good to moderate cholinesterase activities. Synthesized compounds (1–13) were screened in cholinesterase enzyme inhibition assays and showed AChE activities in the range of IC50 = 19.44 ± 0.60 µM to 36.05 ± 0.4 µM against allanzanthane (IC50 = 16.11 ± 0.33 µM) and galantamine (IC50 = 19.34 ± 0.62 µM) and varied BuChE inhibitory activities, with IC50 values in the range of 21.57 ± 0.61 µM to 39.55 ± 0.03 µM as compared with standard allanzanthane (IC50 = 18.14 ± 0.05 µM) and galantamine (IC50 = 21.45 ± 0.21 µM). Similarly, synthesized compounds (14–26) were also subjected to tests to determine their in vitro AChE inhibitory activities, and the results obtained corroborated that all the compounds showed varied activities in the range of IC50 = 22.07 ± 0.13 to 42.01 ± 0.02 µM as compared to allanzanthane (IC50 = 20.01 ± 0.12 µM) and galantamine (IC50 = 18.05 ± 0.31 µM) and varied BuChE inhibitory activities, with IC50 values in the range of 26.32 ± 0.13 to 47.03 ± 0.15 µM as compared to standard allanzanthane (IC50 = 18.14 ± 0.05 µM) and galantamine (IC50 = 21.45 ± 0.21 µM). Binding interactions of the most potent analogs were confirmed through molecular docking studies. The active analogs 2, 4, 10 and 13 established numerous interactions with the active sites of targeted enzymes, with docking scores of −10.50, −9.3, −7.73 and −7.8 for AChE and −8.97, −8.2, −8.20 and −7.6 for BuChE, respectively.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Hazara University, Mansehra 21120, Pakistan.
- Institute of Chemistry, University of Okara, Okara 56130, Pakistan.
- Department of Zoology, Wildlife and Fisheries, University of Agriculture Faisalabad, Sub-Campus Toba Tek Singh, Toba Tek Singh 36080, Pakistan.
- Department of Chemistry, Abbottabad University of Science and Technology, Abbottabad 22500, Pakistan.
- Center for Nanosciences, University of Okara, Okara 56130, Pakistan.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
ORCID-Profile: Hayat Ullah, Shoaib Khan, Amjad Hussain, Mashooq Ahmad Bhat
Förderung
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
Tariq, S., Rahim, F., Ullah, H., Sarfraz, M., Hussain, R., Khan, S., Khan, M. U., Rehman, W., Hussain, A., Bhat, M. A., Farooqi, M. K., Shah, S. A. A., & Iqbal, N. (2024). Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents. Pharmaceuticals, 17(4), 410. https://doi.org/10.3390/ph17040410
Vancouver
Tariq S, Rahim F, Ullah H, Sarfraz M, Hussain R, Khan S, et al. Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents. Pharmaceuticals. 2024;17(4):410. doi:10.3390/ph17040410
BibTeX
@article{Tariq2024,
author = {Tariq, Sundas and Rahim, Fazal and Ullah, Hayat and Sarfraz, Maliha and Hussain, Rafaqat and Khan, Shoaib and Khan, Misbah Ullah and Rehman, Wajid and Hussain, Amjad and Bhat, Mashooq Ahmad and Farooqi, Muhammad Kamran and Shah, Syed Adnan Ali and Iqbal, Naveed},
title = {Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {4},
pages = {410},
doi = {10.3390/ph17040410}
}
EUVIMED